Cannabidiol (CBD) has been a hot topic in recent years, with its potential therapeutic and medical uses being explored by researchers and consumers alike. But is CBD still a controlled substance? The answer is no. Unless specifically and strictly derived from a marijuana plant, CBD is not now, nor has it ever been, a controlled substance. The Drug Enforcement Administration (DEA) has removed a marijuana-based drug from the list of federally controlled substances.
This change can speed up the process for researchers to study cannabis and its derivatives, including CBD, that fall within the definition of hemp, which could accelerate the development of new drugs. The Food and Drug Administration (FDA) has approved Epidiolex, a drug containing purified CBD from hemp, to help treat rare seizure disorders. Months after the launch of Epidiolex, CBD has become its own unique regulatory challenge after breaking into the consumer market in recent years. The FDA has sent warning letters in the past to companies that illegally sold CBD products that claimed to prevent, diagnose, treat or cure serious diseases, such as cancer.
The NBA Players' Union partners with former star Al Harrington on the line of CBD products to be sold by Amazon and Walmart. The FDA is not aware of any evidence that would challenge its current findings that products with THC and CBD are excluded from the definition of a dietary supplement under section 201 (ff) ((B) of the FD&C Act. Therefore, the FDA has concluded that it is prohibited to introduce or deliver for introduction into interstate commerce any food (including food or animal feed) to which THC or CBD has been added. Specifically, this order places FDA-approved drugs that contain cannabis-derived CBD and no more than 0.1 percent tetrahydrocannabinols on Schedule V.If you use products that contain CBD or THC, store them in child-resistant containers and out of reach of children.
There is significant interest in the development of therapies and other consumer products derived from cannabis and its components, including cannabidiol (CBD). Some of these products further violated the FD&C Act because they were marketed as dietary supplements or because they involved the addition of CBD to food. Ingredients that are derived from parts of the cannabis plant that do not contain THC or CBD could fall outside the scope of 301 (II) and, therefore, could be added to food.
